Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Asthma × Beclomethasone × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Thrombocythemia, Essential 1 Sezary Syndrome 1 Respiratory Sounds 1 Recurrence 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1

Interventions

Etanercept 2 NVP-QAV680 1 Beclomethasone 1 Azithromycin 1 Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02517099 2023-03-06

PrIGMa

Imperial College London

Phase 2 Completed

60 enrolled 10 charts

Asthma, Lymphoma, Follicular, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon ⚡